EUVIMEDEUVIMED entdecken
Querschnittstudie

Access to melanoma drugs in Spain: a cross-sectional survey

Maria Gonzalez-Cao, Teresa Puertolas, Jose Luis Manzano, Cayetana Maldonado, Oriol Yelamos, Miguel Ángel Berciano-Guerrero, Pablo Cerezuela, Juan Martin-Liberal, Eva Muñoz-Couselo, Enrique Espinosa, Ana Drozdowskyj, Alfonso Berrocal und 6 weitere

Clinical and Translational Oncology · 16.05.2024 · 26 (10) · 2572-2583

DOI: 10.1007/s12094-024-03501-9 ↗

Kurz gefasst

Querschnittstudie in der Zeitschrift Clinical and Translational Oncology, online erschienen am 16.05.2024. Verfasst von Maria Gonzalez-Cao und 17 weiteren Autor:innen. Beteiligte Einrichtung: Translational Cancer Research Unit, Instituto Oncologico Dr Rosell, Dexeus University Hospital, C/Sabino Arana, 5, 080028, Barcelona, Spain. mgonzale…. Hauptthemen laut MEDLINE: Melanoma, Health Services Accessibility. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 25 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MelanomaHealth Services AccessibilityHumansCross-Sectional StudiesSpainSurveys and QuestionnairesSkin NeoplasmsAntineoplastic AgentsIpilimumabNivolumabImmunotherapy

Stichwörter der Autor:innen

AccessInnovative therapiesMelanoma

Substanzen

Antineoplastic AgentsIpilimumabNivolumab

Autor:innen und Institutionen

  • Translational Cancer Research Unit, Instituto Oncologico Dr Rosell, Dexeus University Hospital, C/Sabino Arana, 5, 080028, Barcelona, Spain. mgonzalezcao@oncorosell.com.
  • Oncology Department, Hospital Miguel Servet, Saragossa, Spain.
  • Oncology Department, Hospital Germans Trias I Pujol, Badalona, Spain.
  • Dermatology Department, Hospital Universitario de Asturias, Oviedo, Spain.
  • Dermatology Department, Hospital de La Santa Creu I Sant Pau, Barcelona, Spain.
  • Oncology Department Hospitales, Universitarios Regional y Virgen de La Victoria (HURyVV), Instituto de Investigaciones Biomédicas de Málaga (IBIMA), Málaga, Spain.

Zitieren

APA

Gonzalez-Cao, M., Puertolas, T., Manzano, J. L., Maldonado, C., Yelamos, O., Berciano-Guerrero, M. Á., Cerezuela, P., Martin-Liberal, J., Muñoz-Couselo, E., Espinosa, E., Drozdowskyj, A., Berrocal, A., Soria, A., Marquez-Rodas, I., Martin-Algarra, S., Quindos, M., Puig, S., & Spanish Melanoma Group (GEM) (2024). Access to melanoma drugs in Spain: a cross-sectional survey. Clinical and Translational Oncology, 26(10), 2572-2583. https://doi.org/10.1007/s12094-024-03501-9

Vancouver

Gonzalez-Cao M, Puertolas T, Manzano JL, Maldonado C, Yelamos O, Berciano-Guerrero MÁ, et al. Access to melanoma drugs in Spain: a cross-sectional survey. Clinical and Translational Oncology. 2024;26(10):2572-2583. doi:10.1007/s12094-024-03501-9

BibTeX
@article{GonzalezCao2024,
  author = {Gonzalez-Cao, Maria and Puertolas, Teresa and Manzano, Jose Luis and Maldonado, Cayetana and Yelamos, Oriol and Berciano-Guerrero, Miguel Ángel and Cerezuela, Pablo and Martin-Liberal, Juan and Muñoz-Couselo, Eva and Espinosa, Enrique and Drozdowskyj, Ana and Berrocal, Alfonso and Soria, Ainara and Marquez-Rodas, Ivan and Martin-Algarra, Salvador and Quindos, Maria and Puig, Susana and Spanish Melanoma Group (GEM), Spanish Melanoma Group (GEM)},
  title = {Access to melanoma drugs in Spain: a cross-sectional survey},
  journal = {Clinical and Translational Oncology},
  year = {2024},
  volume = {26},
  number = {10},
  pages = {2572--2583},
  doi = {10.1007/s12094-024-03501-9}
}
Kostenlos starten →